Back to Search
Start Over
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
- Source :
- GlobeNewswire. May 14, 2024
- Publication Year :
- 2024
-
Abstract
- Potential to alleviate unmet need associated with depressed mood and anhedonia in bipolar depression; navacaprant has demonstrated the ability to improve these symptoms in MDD in a Phase 2 study [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.793682091